retatrutide dosing in clinical trials ESC 2024: improves lipid and cardiovascular risk profile Phase II trial ✨ New Dosage Options &

A practical approach

Regulatory environment supports continued innovation in obesity treatment with streamlined approval pathways for novel GLP-1 formulations

Clinical trials have followed patients for multiple years without identifying new safety concerns that emerge with longer use

Shauna Levy, medical director for the Tulane Weight Loss Center, says that doesnt mean it doesnt work, but that the medical community just doesnt know

The most common dosages for weight loss are 2.4 mg once a week or 1.0 mg once a day

The doses studied in clinical trials range from 1mg to 12mg, with 12mg being the highest dose tested and producing the greatest weight loss (-24.2% at 48 weeks in Phase 2, -28.7% at 68 weeks in Phase 3)